The International Pharmaceutical Federation (FIP) has offered a new resource to help countries self-assess readiness of their regulations to enable
pharmacist-delivered vaccination services and, where needed, to implement such regulations.
Developed by FIP's Regulators Advisory Group, it covers broad pharmacist-led roles related to vaccination from supply chain management to administration and
prescribing.
"This new resource from FIP is based on the experiences of professional regulators in countries where pharmacy-led vaccination has been successfully introduced
and regulated. With it, we aim to support regulators, policymakers and national organisations in developing strategies or enabling regulatory frameworks in
countries where the pharmacy workforce has a limited role in vaccination strategies so that it can contribute further to the global imperative of improving
immunisation coverage," said Brett Simmonds, group chair.
The "Pharmacy-led vaccination services: Regulatory self-assessment and implementation tool" aims to help identify strengths and areas for improvement in order to
inform vaccination policy and planning efforts.
The World Health Organization called for caution on Tuesday (May 16) in using artificial intelligence for public healthcare, saying data used by AI to reach
decisions could be biased or misused.
The WHO said it was enthusiastic about the potential of AI but had concerns over how it will be used to improve access to health information, as a decision-support
tool and to improve diagnostic care.
The WHO said in a statement the data used to train AI may be biased and generate misleading or inaccurate information and the models can be misused to generate
disinformation.
It was "imperative" to assess the risks of using generated large language model tools (LLMs), like ChatGPT, to protect and promote human wellbeing and protect public
health, the U.N. health body said.
Ventricular Septal Defect, a congenital heart condition characterized by a hole in the septum, the wall that separates the heart's lower chambers, poses a significant threat to cardiac health. Addressing VSD through surgery becomes imperative to restore normal cardiac function and prevent life-threatening consequences.
If you're thinking of heading a startup, owning a local pharmacy could be an incredibly lucrative opportunity. When you set up a business in the healthcare
sector, it's important to ensure that you operate with transparency to keep yourself and your patients safe.
Whether you've acquired pharmacies before or you're turning to a new venture with different partners, learning the relevant steps before getting involved is
imperative. Successful pharmacies rely on medical expertise, professional knowledge, and an excellent quality of service.
Step 1: Do you need qualifications to be a pharmacist?
No matter if you already have a background in pharmacy or you're entering the field from an entrepreneurial perspective, you'll need to have the right qualifications.
You can become a pharmacist by completing a Master of Pharmacy degree at a university. Your chosen course needs to be approved by the General Pharmaceutical Council
and will take at least four years to complete. After your degree, you'll also need to take the one-year pharmacist foundation training scheme.
To access these courses, you'll usually need two or three A levels, including Chemistry. Alternatively, you could do a pharmacy foundation degree if you only have one
A level or equivalent.
The National Pharmacy Association (NPA) has asked the Secretary of State for Health and Social Care to convene a 'medicines supply taskforce', following weeks
of problems with antibiotics supplies.
The NPA's chief executive Mark Lyonette wrote a letter to Steve Barclay this week. It cited the precedent of the HRT Taskforce which this summer brought together
representatives from across the supply chain after months of supply problems affecting women.
"We strongly believe that this situation calls for a similar response from the government. It is imperative that we resolve this supply situation urgently and
therefore we request that you convene a Medicines Supply Taskforce, with all the relevant stakeholders in the supply chain, to urgently discuss and agree practical
solutions to address the disruptions to the supply of medicines. HRT and antibiotics are the most visible examples of a wider problem with medicines supply
which needs to be addressed."
NPA board members Olivier Picard and Reena Barai were among the stakeholders joining meetings convened by the HRT Taskforce this summer.
In a significant development, the British Medical Association's (BMA) consultants committee has voted to accept the government's offer on pay for senior
doctors in England, along with proposed reforms to the Review Body on Doctors' and Dentists' Remuneration (DDRB).
This decision follows a prolonged dispute between consultants and the government, which spanned over a year, involving unprecedented industrial actions.
Committee Chair Vishal Sharma described the agreement as "the end of the beginning" in consultants' endeavors to restore their pay levels to those of 2008.
Stressing the importance of the review body's independence in averting future pay disputes, Sharma emphasized the imperative role of utilizing this autonomy
effectively.
A staggering 83% of consultants participating in the three-week referendum voted in favor of accepting the offer, signaling a widespread endorsement of the
agreement within the profession.
As Prime Minister Rishi Sunak announces the forthcoming UK general election, pharmacy bodies are calling on all political parties to commit to solving the
issues facing the sector.
The next UK general election will be held on 4 July, Sunak announced it on Wednesday afternoon during a press conference outside 10 Downing Street.
"As the election is called it's imperative that any incoming government addresses the crisis in primary care and the looming cliff edge facing pharmacies, which
for millions of people are the front door to the NHS and a crucial source of frontline health care," said Paul Rees, Chief Executive of the National Pharmacy
Association (NPA).
Noting that the first responsibility of the government is to keep its people safe and healthy, he emphasised the importance of addressing the "deep funding gap
that is pushing record numbers of pharmacies to the edge of closure and beyond, exacerbating the issues of waiting lists for GPs and hospital care."
Lightweight travel wheelchair is a Transport Wheelchair that has a lightweight frame and many features that are common on Transporters.Light travel wheelchairs are great for road trips and travel tours, you can go anywhere with a Travel chair, the frame is light and easy to fold and store, this type of wheelchair fits easily into the trunk of your car, or if you are traveling by plane, bus, or train.
We provide Lightweight Travel Wheelchair that are dependable and easy to carry or fold, our Transport Wheelchair Series includes travel wheelchairs that have many unique features. We also carry the original and upgraded "Airplane Wheelchair", which is specifically used for plane travel, meaning that it was designed to fit in an airplane, through the aisles and through the doors, and through the bridge.
Transport chairs, also known as companion wheelchairs, have four small wheels instead of two small and two large. A transport chair is designed to only be push by caregiver, other common names are 'companion chair' or 'rollabout chair'. A huge variety of different widths and weight capacities are available. A transport wheelchair is a mobility chair designed for convenience, short-distance use and easy handling by a caregiver. Lightweight and foldable, these wheelchairs are easily moved and typically fit in the trunk of most vehicles. There is even a model designed to fold into a bag to be carried over the shoulder. They are much smaller than standard manual wheelchairs and similar in size to the front wheels. Without large rear wheels, the user must rely on someone else to push the chair, which is why the transport chair is often referred to as a companion wheelchair.
Karma Travel Wheelchair KM TV 20.2:
Karma Travel Wheelchair KM TV 20.2 - 606 T-6 aircraft-grade aluminum-alloy frame provides incredible strength. Easy-to-fold in three seconds.
Karma Travel Wheelchair KM TV 20.2 Features:
Type: Travel Wheelchair
T-6 aircraft-grade aluminum
Secure brake improve safety
Padded flip back armrest
PU front caster & rear wheel
Karma Travel Wheelchair KM TV 20.2 Measurements:
Weight: 8.9kg
Seat width: 39.5cm
Tyre: PU front casters and rear wheels
Capacity: 100kg
Folded size: (L/W/H): 610mm x 350mm x710mm.
Ultra Lightweight Wheelchair:
Its compact design and feather light weight makes it suitable for people on the go.
Ultra Lightweight Wheelchair Specifications:
Frame Style : Foldable
Frame Material : Aluminium (Light weight)
Rear wheel to wheel width in open position (inches) : 20"
Handle to Handle : 16"
Seat Width (inches): 13"
Rear Wheel Size: 7"
Front Wheel Size: 5"
Seat to floor height (inches): 19"
Seat Depth (inches): 13"
Back height (inches): 16"
Total height (inches): 35"
Max User Weight Capacity (kgs): 80 k.g.
Net Weigh
Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document published
by Nuffield Trust and The King's Fund has revealed. It says community pharmacies in England must adapt to changing population needs amidst unprecedented health
and care challenges.
Commissioned by Community Pharmacy England, the report titled 'A Vision for Community Pharmacy', published on Sept. 19, is a result of almost a year of research
and extensive consultation with the sector and wider stakeholders, advocating for community pharmacy. The think tanks detail a shift in the community pharmacy
sector, highlighting how pharmacies can contribute to crucial policy objectives regarding population health, prevention, and the increasing demand in primary care.
"The health and care needs of the population are evolving, and pharmacies in England, like all components of the health and care system, must adjust to address
these changes," said Helen Buckingham, Director of Strategy at Nuffield Trust.